Phase II Trial of R-CVP Followed By Rituximab Maintenance Therapy for Patients with Advanced Stage Marginal Zone Lymphoma- Consortium for Improving Survival of Lymphoma (CISL) Study
Year: 2016
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Sung Yong Oh, Won Seog Kim, Jin Seok Kim, Seok Jin Kim, Suee Lee, Dok Hyun Yoon, Deok-Hwan Yang, Won Sik Lee, Hyo Jung Kim, Ho-Young Yhim, Seong Hyun Jeong, Jong Ho Won, Jee Hyun Kong, Sung-Nam Lim, Jun Ho Ji, Kyung A Kwon, Gyeong-Won Lee, Jae Hoon Lee, Ho Sup Lee, Ho-Jin Shin, Cheolwon Suh
Institutions: Dong-A University, Samsung Medical Center, Sungkyunkwan University, Yonsei University, Yonsei University Health System, Asan Medical Center, University of Ulsan, Chonnam National University Hwasun Hospital, Inje University Busan Paik Hospital, Hallym University Sacred Heart Hospital, Jeonbuk National University, Ajou University, Soonchunhyang University Hospital Seoul, Wonju Severance Christian Hospital, Inje University, Inje University Haeundae Paik Hospital, Samsung Changwon Hospital, Dongnam Institute of Radiological & Medical Sciences, Gyeongsang National University, Gyeongsang National University Hospital, Gachon University Gil Medical Center, Kosin University Gospel Hospital, Pusan National University Hospital
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2610259949